Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

New compound targets enzyme linked to autoimmune disorders, severe COVID-19

worldpharmanewsMarch 12, 2021

Tag: NTU Singapore , COVID-19 , autoimmune , TYK2

PharmaSources Customer Service